MedPath

Diabetes text message self management support

Not Applicable
Completed
Conditions
Diabetes
Metabolic and Endocrine - Diabetes
Public Health - Other public health
Registration Number
ACTRN12614001232628
Lead Sponsor
niversity of Auckland
Brief Summary

The aim of the study was to evaluate whether a text message programme (SMS4BG) was effective in supporting people with diabetes. Half of the people in the study received a text message programme over a 3- to 9-month period (SMS4BG group). The other half did not receive the programme in this period (this is the ‘usual care’ group). 366 people took part in the study, with 183 in the SMS4BG group and 183 in the usual care group. We found that those who received the SMS4BG programme had a greater improvement in their HbA1c (diabetes control) at 9-month follow up compared to those in the usual care group. A decrease in HbA1c from baseline to 9-month follow up was seen in 75% of the participants in the SMS4BG group and 59% of usual care group. Of the people who received the SMS4BG programme: o 95% reported that they found it useful o 97% would recommend the programme to others with diabetes o 99% thought that text messaging was a good way to deliver this type of support o 82% said that the SMS4BG impacted on how they manage their diabetes or helped change their behaviours o 71% reported that taking part in the programme helped them to learn about their diabetes o Less than 2% chose to end the messages early

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
366
Inclusion Criteria

1. Aged 16 years or older
2. Have type 1 or type 2 diabetes
3. Have an HbA1c>65mmol/mol within the preceding 9 months
4. Have a mobile phone that can be used for this program
5. Provides informed consent
6. Able to read English

Exclusion Criteria

1. Not available for the duration of the programme
2. Unable to use a mobile phone due to physical disabilities affecting eyesight or dexterity and do not have a carer who wishes to use the mobile tools on their behalf.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in HbA1c as measured by blood test[Baseline and 9 months]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath